4/16
11:37 am
regn
NTLA Stock Rises 20% in 3 Months: Here's What You Should Know [Yahoo! Finance]
Low
Report
NTLA Stock Rises 20% in 3 Months: Here's What You Should Know [Yahoo! Finance]
4/14
07:35 am
regn
Why Telix Pharmaceuticals (ASX:TLX) Is Up 13.8% After Regeneron Radiopharma Alliance Announcement And What's Next [Yahoo! Finance]
Low
Report
Why Telix Pharmaceuticals (ASX:TLX) Is Up 13.8% After Regeneron Radiopharma Alliance Announcement And What's Next [Yahoo! Finance]
4/13
06:30 am
regn
Regeneron and Telix Announce Strategic Radiopharma Collaboration
Low
Report
Regeneron and Telix Announce Strategic Radiopharma Collaboration
4/13
01:00 am
regn
Dupixent® (dupilumab) Approved in the EU as the First Targeted Medicine to Treat Young Children with Chronic Spontaneous Urticaria (CSU)
Low
Report
Dupixent® (dupilumab) Approved in the EU as the First Targeted Medicine to Treat Young Children with Chronic Spontaneous Urticaria (CSU)
4/12
06:57 pm
regn
Telix and Regeneron Announce Strategic Radiopharma Collaboration
Low
Report
Telix and Regeneron Announce Strategic Radiopharma Collaboration
4/10
11:51 am
regn
Regeneron Pharmaceuticals (REGN) had its price target raised by Morgan Stanley from $769.00 to $796.00. They now have an "equal weight" rating on the stock.
Low
Report
Regeneron Pharmaceuticals (REGN) had its price target raised by Morgan Stanley from $769.00 to $796.00. They now have an "equal weight" rating on the stock.
4/8
09:47 am
regn
Regeneron Pharmaceuticals (REGN) had its price target lowered by Sanford C. Bernstein from $925.00 to $921.00. They now have an "outperform" rating on the stock.
Low
Report
Regeneron Pharmaceuticals (REGN) had its price target lowered by Sanford C. Bernstein from $925.00 to $921.00. They now have an "outperform" rating on the stock.
4/5
09:01 pm
regn
TriNetX ?Regeneron????????3??????????????????????????????????????????????·??????? [CNET News]
Low
Report
TriNetX ?Regeneron????????3??????????????????????????????????????????????·??????? [CNET News]
4/5
05:18 am
regn
How Trump's 100% drug tariffs could reach consumers pocketbooks [USA TODAY]
Low
Report
How Trump's 100% drug tariffs could reach consumers pocketbooks [USA TODAY]
4/5
05:14 am
regn
How Trump's 100% drug tariffs could reach consumers pocketbooks [Yahoo! Finance]
Low
Report
How Trump's 100% drug tariffs could reach consumers pocketbooks [Yahoo! Finance]
4/3
11:42 pm
regn
Regeneron Eyes Longer EYLEA HD Dosing As Valuation Gap Persists [Yahoo! Finance]
Low
Report
Regeneron Eyes Longer EYLEA HD Dosing As Valuation Gap Persists [Yahoo! Finance]
4/2
05:26 pm
regn
TriNetX Collaborates with Regeneron to Access De-Identified Electronic Health Records of 300 Million Patients to Drive Research and Product Development in Life Sciences and Digital Health Solutions [Yahoo! Finance]
Low
Report
TriNetX Collaborates with Regeneron to Access De-Identified Electronic Health Records of 300 Million Patients to Drive Research and Product Development in Life Sciences and Digital Health Solutions [Yahoo! Finance]
4/2
04:43 pm
regn
TriNetX Collaborates with Regeneron to Access De-Identified Electronic Health Records of 300 Million Patients to Drive Research and Product Development in Life Sciences and Digital Health Solutions [TheStreet.com]
Low
Report
TriNetX Collaborates with Regeneron to Access De-Identified Electronic Health Records of 300 Million Patients to Drive Research and Product Development in Life Sciences and Digital Health Solutions [TheStreet.com]
4/2
04:34 pm
regn
TriNetX Collaborates with Regeneron to Access De-Identified Electronic Health Records of 300 Million Patients to Drive Research and Product Development in Life Sciences and Digital Health Solutions
Low
Report
TriNetX Collaborates with Regeneron to Access De-Identified Electronic Health Records of 300 Million Patients to Drive Research and Product Development in Life Sciences and Digital Health Solutions
4/2
04:30 pm
regn
TriNetX Collaborates with Regeneron to Access De-Identified Electronic Health Records of 300 Million Patients to Drive Research and Product Development in Life Sciences and Digital Health Solutions
Low
Report
TriNetX Collaborates with Regeneron to Access De-Identified Electronic Health Records of 300 Million Patients to Drive Research and Product Development in Life Sciences and Digital Health Solutions
4/2
04:30 pm
regn
TriNetX Collaborates with Regeneron to Access De-Identified Electronic Health Records of 300 Million Patients to Drive Research and Product Development in Life Sciences and Digital Health Solutions
Low
Report
TriNetX Collaborates with Regeneron to Access De-Identified Electronic Health Records of 300 Million Patients to Drive Research and Product Development in Life Sciences and Digital Health Solutions
4/2
04:30 pm
regn
Regeneron Collaborates with TriNetX to Access De-Identified Electronic Health Records of 300 Million Patients to Drive Research and Product Development in Life Sciences and Digital Health Solutions
Low
Report
Regeneron Collaborates with TriNetX to Access De-Identified Electronic Health Records of 300 Million Patients to Drive Research and Product Development in Life Sciences and Digital Health Solutions
4/2
02:35 pm
regn
Regeneron says it expects to avoid new US pharma tariffs [Yahoo! Finance]
Low
Report
Regeneron says it expects to avoid new US pharma tariffs [Yahoo! Finance]
4/2
12:55 pm
regn
EYLEA HD® (aflibercept) Approved by FDA as First and Only Injectable Anti-VEGF with Dosing Intervals Up to 5 Months for Wet Age-related Macular Degeneration (wAMD) and Diabetic Macular Edema (DME) [Yahoo! Finance]
Low
Report
EYLEA HD® (aflibercept) Approved by FDA as First and Only Injectable Anti-VEGF with Dosing Intervals Up to 5 Months for Wet Age-related Macular Degeneration (wAMD) and Diabetic Macular Edema (DME) [Yahoo! Finance]
4/2
12:00 pm
regn
EYLEA HD® (aflibercept) Approved by FDA as First and Only Injectable Anti-VEGF with Dosing Intervals Up to 5 Months for Wet Age-related Macular Degeneration (wAMD) and Diabetic Macular Edema (DME)
Low
Report
EYLEA HD® (aflibercept) Approved by FDA as First and Only Injectable Anti-VEGF with Dosing Intervals Up to 5 Months for Wet Age-related Macular Degeneration (wAMD) and Diabetic Macular Edema (DME)
3/31
03:32 pm
regn
A Look At Regeneron Pharmaceuticals (REGN) Valuation After Japan's Approval Of Dupixent For Bullous Pemphigoid [Yahoo! Finance]
Low
Report
A Look At Regeneron Pharmaceuticals (REGN) Valuation After Japan's Approval Of Dupixent For Bullous Pemphigoid [Yahoo! Finance]
3/31
11:27 am
regn
Regeneron Pharmaceuticals (REGN) had its price target lowered by Truist Financial Corporation from $818.00 to $801.00. They now have a "buy" rating on the stock.
Low
Report
Regeneron Pharmaceuticals (REGN) had its price target lowered by Truist Financial Corporation from $818.00 to $801.00. They now have a "buy" rating on the stock.
3/31
08:41 am
regn
Regeneron Pharmaceuticals (REGN) is now covered by Piper Sandler. They set an "overweight" rating and a $875.00 price target on the stock.
Low
Report
Regeneron Pharmaceuticals (REGN) is now covered by Piper Sandler. They set an "overweight" rating and a $875.00 price target on the stock.
3/30
07:16 am
regn
Regeneron Pharma (REGN) Shares Up After Jim Cramer Called It a Good Stock [Yahoo! Finance]
Low
Report
Regeneron Pharma (REGN) Shares Up After Jim Cramer Called It a Good Stock [Yahoo! Finance]
3/27
08:58 am
regn
Is Regeneron a Multimillionaire-Maker Stock? [Yahoo! Finance]
Low
Report
Is Regeneron a Multimillionaire-Maker Stock? [Yahoo! Finance]